Antengene Corporation Limited
About
4.45HKD+0.32 +7.75%
Closed • Updated at 06:33 GMT+00:00Market Cap$334.12M
Volume2.45M
Beta1.67
RSI40.51
Gross Margin64.94%
Antengene Corporation Limited — investor relations, events, news, and company updates on 6ix.
Latest News
May 28 2026
Antengene Receives CDE Endorsement to Initiate Pivotal Phase III CLINCH-3 Study of ATG-022 in CLDN18.2+ Advanced Gastric/GEJ Cancer
May 20 2026
Antengene Appoints Dr. Bing Hou as Chief Scientific Officer to Lead Innovation-Driven R&D Strategy and Advance Next-Generation Pipeline
Apr 18 2026
Antengene Presents Three Novel Programs at AACR 2026, Highlighting Next-Generation ADC and AnTenGager® TCEs
Mar 20 2026
Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability
Mar 18 2026
Antengene to Present on Three Preclinical Programs at AACR 2026, Highlighting Next-Generation ADCs and AnTenGager™ TCEs
Community Chat
Ask AI
Try asking